IRMA IN CML (IMATINIB RESISTANCE MUTATION ANALYSIS)
IRMA IN CML (IMATINIB RESISTANCE MUTATION ANALYSIS)

This test is useful for detecting over 90 known and novel mutations in ABL kinase domain of Ph chromosome including T3151 and P-loop mutations responsible for resistance to Imatinib in CML patients. Imatinib is a Tyrosine kinase inhibitor (TKI) which helps in overcoming mutations to aid in the treatment of CML.

Sample Type - Blood

Reporting Time - Please Call Customer care

Prerequisites - No special preparation required

Price - ₹10290/-

Add to cart Go Home